Home › NDC Lookup › RxCUI directory › RxCUI 1247658

Glycopyrrolate 1.5 MG Oral Tablet — RxCUI 1247658

RxNorm drug concept · Semantic clinical drug
RxCUI 1247658 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1247658
Official nameGlycopyrrolate 1.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped3
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Glycopyrronium Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Qbrexza is a medicated cloth you wipe under your arms once a day. It contains glycopyrronium, which blocks the signal your nerves send to your sweat glands. The result is that your...
  • What exactly is Qbrexza and what is it supposed to do?
  • Each pouch holds one pre-moistened cloth. Tear it open, unfold the cloth, and wipe it across one underarm once — then use that same cloth on your other underarm. Apply it to clean,...
  • Dry mouth is the most common one — about 1 in 4 people in trials noticed it. You might also experience blurred vision, dilated pupils, mild difficulty urinating, headache, or dryne...
📖 Read our full Glycopyrronium Topical guide →

🕸️ Concept Web — How Glycopyrrolate 1.5 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Glycopyrrolate 1.5 MG Oral Tablet RxCUI 1247658

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Glycopyrronium 1546438
    • Glycopyrrolate 4955
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Glycate 1437970
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Glycopyrronium Oral Tablet 372340
    • Glycopyrrolate Oral Tablet 2646842
    • Glycopyrronium Oral Product 2109873
    • Glycopyrronium Pill 2109871
    • Glycopyrrolate Oral Product 2661028
    • Glycopyrrolate Pill 2662994
    • Glycopyrronium Oral Tablet [Glycate] 1437972
    • Glycopyrrolate Oral Tablet [Glycate] 2656473
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Glycopyrrolate 1.5 MG SCDC · 1247657
  • Glycopyrronium Oral Tablet SCDF · 372340
  • Glycopyrrolate Oral Tablet SCDFP · 2646842
  • Glycopyrronium Oral Product SCDG · 2109873
  • Glycopyrronium Pill SCDG · 2109871
  • Glycopyrrolate Oral Product SCDGP · 2661028
  • Glycopyrrolate Pill SCDGP · 2662994

Brand-Name Concepts

  • Glycopyrrolate 1.5 MG Oral Tablet [Glycate] SBD · 1437975
  • Glycopyrrolate 1.5 MG [Glycate] SBDC · 1437971
  • Glycopyrronium Oral Tablet [Glycate] SBDF · 1437972
  • Glycopyrrolate Oral Tablet [Glycate] SBDFP · 2656473
  • Glycate Oral Product SBDG · 1437973
  • Glycate Pill SBDG · 1437974
  • Glycate BN · 1437970

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 1247658 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
72887-0160-03 30 TABLET in 1 BOTTLE (72887-160-03) GLYCOPYRROLATE FH2 Pharma LLC 2021-11-29
79739-7097-01 100 TABLET in 1 BOTTLE, PLASTIC (79739-7097-1) Glycopyrrolate LGM PHARMA SOLUTIONS, LLC 2012-03-12
80056-0160-10 100 TABLET in 1 BOTTLE (80056-160-10) Glycate Intra-Sana Laboratories 2022-04-01
Observed labelers: FH2 Pharma LLC (1) · Intra-Sana Laboratories (1) · LGM PHARMA SOLUTIONS, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.